How is Cangrelor dosed?
Cangrelor is available in the form of a powder for solution. The appropriate dosage of cangrelor intravenous route should be determined by a healthcare professional based on individual medical history and conditions. It is not recommended for use in children, as safety and efficacy have not been established. In the elderly population, no specific geriatric-related problems have been demonstrated. Caution should be exercised when using cangrelor while breastfeeding, as there are no adequate studies to determine the risk. It is important to inform your doctor about all medications and supplements you are currently taking, as drug interactions may occur.
What is the dosage form of Cangrelor?
The dosage form of cangrelor intravenous route is Powder for Solution.
What medications are contraindication with Cangrelor?
Cangrelor intravenous route is contraindicated with the following medications:
- Rivaroxaban
- Rofecoxib
- Salicylic Acid
- Salsalate
- Sertraline
- Sodium Salicylate
- Sulindac
- Tenoxicam
- Tiaprofenic Acid
- Tolfenamic Acid
- Tolmetin
- Valdecoxib
- Vilazodone
- Vortioxetine
- Warfarin Alcohol and tobacco use can also potentially cause interactions with cangrelor. It is important to discuss with your healthcare professional the use of your medication with food, alcohol, or tobacco.
How is Cangrelor administered?
Cangrelor intravenous route is administered by a healthcare professional in a hospital or medical setting. The powder for solution form of cangrelor is mixed with a liquid to create a solution that is then injected intravenously (into a vein) for patients undergoing percutaneous coronary intervention (PCI) to lower the risk of blood clots and heart attack.
What are common precautions when taking Cangrelor?
Here are some common precautions to consider when taking cangrelor intravenous route:
- Medical Supervision: Cangrelor should be given only by or under the supervision of a doctor.
- Allergies: Inform your doctor if you have any allergies to cangrelor or any other medications, foods, dyes, preservatives, or animals.
- Breastfeeding: There is limited information on the safety of cangrelor use during breastfeeding. Consult your doctor before taking this medication while breastfeeding.
- Pediatric Use: The safety and effectiveness of cangrelor have not been established in the pediatric population. Consult your doctor for further guidance.
- Geriatric Use: Cangrelor has not been found to have any specific problems in elderly patients. However, your doctor may adjust the dosage based on age or other factors.
- Bleeding Risk: Cangrelor may increase the risk of serious bleeding in some people. Inform your doctor if you have a history of bleeding disorders, liver disease, or if you are taking other medications that may increase the risk of bleeding.
- Pregnancy: Cangrelor should be used cautiously during pregnancy. Consult your doctor if you are pregnant or planning to become pregnant. These precautions provide general guidance. Your doctor will provide personalized instructions based on your medical history, current medications, and other factors. Always follow your doctor's advice for the best results.